XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity
Globe Newswire•18/09/2026•08:05 ET
0
Get started
Create a free account to read the full story and Whiz Insights.
Create a free account to read the full story and Whiz Insights.